Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Busulfan/fludarabine

Treatment related mortality: case report

    • 4 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Koh K-N, et al. Favorable Outcome with Durable Chimerism after Allogeneic Hematopoietic Cell Transplantation Using Busulfan and Fludarabine-Based Reduced-Intensity Conditioning for Children with Hemophagocytic Lymphohistiocytosis. Biology of Blood and Marrow Transplantation 26 (Suppl.): S290 abstr. 442, No. 3, Mar 2020. Available from: URL: http://doi.org/10.1016/j.bbmt.2019.12.563 [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Busulfan/fludarabine. Reactions Weekly 1790, 65 (2020). https://doi.org/10.1007/s40278-020-74684-6

    Download citation